Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 2 The effect of human recombinant IGF-1 and temocapril on echocardiographic data. The graphs show serial transthoracic echocardiographic measurements, LV end-diastolic dimension (LV EDD) (A); estimated LV weight to body weight ratio (LV/BW) (B); relative wall thickness (RWT) (C); and LV fractional shortening (FS) (D), for the IGF-1-treated group (n = 8; open circles), the temocapril-treated group (n = 10; filled circles), and the control group (n = 10; open inverted triangles). Values are expressed as mean ± SEM. *p < 0.05.
|
